Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients
Clinical trial NCT02307643 · COMPLETED
Trial details
- NCT number
- NCT02307643
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-05-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.